Spurlock Charles F, Crooke Philip S, Aune Thomas M
Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232; and.
Department of Mathematics, Vanderbilt University, Nashville, TN 37232.
J Immunol. 2016 Dec 15;197(12):4509-4517. doi: 10.4049/jimmunol.1600970.
The central dogma of molecular biology states that DNA makes RNA makes protein. Discoveries over the last quarter of a century found that the process of DNA transcription into RNA gives rise to a diverse array of functional RNA species, including genes that code for protein and noncoding RNAs. For decades, the focus has been on understanding how protein-coding genes are regulated to influence protein expression. However, with the completion of the Human Genome Project and follow-up ENCODE data, it is now appreciated that only 2-3% of the genome codes for protein-coding gene exons and that the bulk of the transcribed genome, apart from ribosomal RNAs, is at the level of noncoding RNA genes. In this article, we focus on the biogenesis and regulation of a distinct class of noncoding RNA molecules termed long, noncoding RNAs in the context of the immune system.
分子生物学的中心法则指出,DNA产生RNA,RNA产生蛋白质。过去二十五年的研究发现,DNA转录为RNA的过程产生了各种各样的功能性RNA分子,包括编码蛋白质的基因和非编码RNA。几十年来,研究重点一直是理解蛋白质编码基因如何被调控以影响蛋白质表达。然而,随着人类基因组计划的完成以及后续的ENCODE数据,现在人们认识到只有2-3%的基因组编码蛋白质编码基因外显子,并且除了核糖体RNA外,大部分转录基因组处于非编码RNA基因水平。在本文中,我们将在免疫系统的背景下,重点关注一类独特的非编码RNA分子——长链非编码RNA的生物合成和调控。